Imidazole → (R)-tert-butyl 3-(4-(1H-imidazol-1-yl)phenyl)-1-amino-1-oxopropan-2-ylcarbamate

HRID 84900Notes

Reaction equation

HRID 84900 reaction equation
[NH2:1][C:2](=[O:20])[C@H:3]([NH:12][C:13](=[O:19])[O:14][C:15]([CH3:18])([CH3:17])[CH3:16])[CH2:4][C:5]1[CH:10]=[CH:9][C:8](I)=[CH:7][CH:6]=1.[NH:21]1[CH:25]=[CH:24][N:23]=[CH:22]1.OC1C=CC=C2C=1N=CC=C2.C([O-])([O-])=O.[K+].[K+]>CS(C)=O.[Cu]I>[N:21]1([C:8]2[CH:9]=[CH:10][C:5]([CH2:4][C@@H:3]([NH:12][C:13](=[O:19])[O:14][C:15]([CH3:18])([CH3:17])[CH3:16])[C:2]([NH2:1])=[O:20])=[CH:6][CH:7]=2)[CH:25]=[CH:24][N:23]=[CH:22]1

Participants

7

Procedure

A mixture of (R)-tert-butyl 1-amino-3-(4-iodophenyl)-1-oxopropan-2-ylcarbamate (370 mg, 0.948 mmol), imidazole (85 mg, 1.25 mmol), 8-hydroxyquinoline (30 mg, 0.206 mmol), K2CO3 (150 mg, 1.08 mmol) and CuI (20 mg, 0.105 mmol) in DMSO (4 mL) was degassed with argon, then was stirred at 130 C for 18 h. The mixture was purified by HPLC to give (R)-tert-butyl 3-(4-(1H-imidazol-1-yl)phenyl)-1-amino-1-oxopropan-2-ylcarbamate (250 mg).

Workup

  1. customwas degassed with argon
  2. customThe mixture was purified by HPLC

Sources & evidence

ORD record
ord-d7fe933bdda24ad6b76f3c6b11cec7f0
Source dataset
uspto-grants-2014_09
Patent number
US08846928B2

Reaction notes

Loading…